Advertisement
Advertisement
GLMD
Galmed Pharmaceuticals Ltd.
0.59
USDSponsored
+0.02
+2.71%
Jun 24, 16:00 UTC -4
Closed
After-Market
0.57
-0.02
-3.32%
GLMD Earnings Reports
Positive Surprise Ratio
GLMD beat 23 of 37 last estimates.
62%
Next Report
Date of Next Report
Aug 26, 2026
Estimate for Q2 26 (Revenue/ EPS)
--
/-$0.39
Implied change from Q1 26 (Revenue/ EPS)
--
/--
Implied change from Q2 25 (Revenue/ EPS)
--
/-38.10%
Galmed Pharmaceuticals Ltd. earnings per share and revenue
On Jun 17, 2026, GLMD reported earnings of -- USD per share (EPS) for Q1 26, -- the estimate of -0.38 USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.
Looking ahead to Q2 26, -- analysts forecast an EPS of -0.39 USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
FAQ
What were Galmed Pharmaceuticals Ltd.'s earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Galmed Pharmaceuticals Ltd. reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
How did the market react to Galmed Pharmaceuticals Ltd.'s Q1 2026 earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is Galmed Pharmaceuticals Ltd. expected to report next?
The next earning report is scheduled for Aug 26, 2026.
What are the forecasts for Galmed Pharmaceuticals Ltd.'s next earnings report?
Based on --
analysts, Galmed Pharmaceuticals Ltd. is expected to report EPS of -$0.39 and revenue of -- for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement